| 1119 |
Failure in gamma-glutamyl carboxylation of glutamine residues on clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin)
Short Name
Failure in gamma-glutamyl carboxylation of glutamine residues on clotting factors II, VII,
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1120 |
Under carboxylated clotting factors will not assemble on cell surfaces , Failure to form clot
Short Name
Under carboxylated clotting factors will not assemble on cell surfaces , Failure to form cl
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1121 |
Hemorrhage , organ dysfunction, hypovolemic shock
Short Name
Hemorrhage , organ dysfunction, hypovolemic shock
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1122 |
Under carboxylated clotting factors will not assemble on cell surfaces to form clot, Failure of secondary hemostasis
Short Name
Under carboxylated clotting factors will not assemble on cell surfaces to form clot, Failur
|
1 |
Tissue |
Nov 29, 2016 |
Dec 3, 2016 |
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|
| 1123 |
Hemorrhage, organ dysfunction, hypovolemic shock, Impaired oxygen delivery to tissue
Short Name
Hemorrhage, organ dysfunction, hypovolemic shock, Impaired oxygen delivery to tissue
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1124 |
Hemorrhage , Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal
Short Name
Hemorrhage , Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon diox
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1125 |
Impaired oxygen and nutrient delivery to tissue, impaired removal of carbon dioxide and other waste products, Hemorrhage, organ dysfunction and hypovolemic shock
Short Name
Impaired oxygen and nutrient delivery to tissue, impaired removal of carbon dioxide and oth
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1126 |
Unresolved blood loss, Failure in vascular repair mechanisms
Short Name
Unresolved blood loss, Failure in vascular repair mechanisms
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1127 |
Anemia, Impaired oxygen and nutrient delivery to tissue, impaired carbon dioxide and waste product removal
Short Name
Anemia, Impaired oxygen and nutrient delivery to tissue, impaired carbon dioxide and waste
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1128 |
Unresolved hemorrhage, Failure in vascular repair mechanisms
Short Name
Unresolved hemorrhage, Failure in vascular repair mechanisms
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1129 |
Unresolved blood loss (hemorrhage), Failure in vascular repair mechanisms
Short Name
Unresolved blood loss (hemorrhage), Failure in vascular repair mechanisms
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1130 |
Failure in vascular repair mechanisms, Unresolved blood loss (hemorrhage)
Short Name
Failure in vascular repair mechanisms, Unresolved blood loss (hemorrhage)
|
2 |
Organ |
Nov 29, 2016 |
Sep 16, 2017 |
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|
| 1131 |
Failure in gamma-glutamyl carboxylation of clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin)
Short Name
Failure in gamma-glutamyl carboxylation of clotting factors II, VII, IX and X, Under carbo
|
4 |
Molecular |
Nov 29, 2016 |
Dec 3, 2016 |
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|
| 1132 |
Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal
Short Name
Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tis
|
3 |
Cellular |
Nov 29, 2016 |
Dec 3, 2016 |
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|
| 1133 |
Hemostasis, Depletion from blood of fully functional carboxylated clotting factors
Short Name
Hemostasis, Depletion from blood of fully functional carboxylated clotting factors
|
2 |
Tissue |
Nov 29, 2016 |
Dec 3, 2016 |
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|
| 1134 |
Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone
Short Name
Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle
|
3 |
Molecular |
Nov 29, 2016 |
Dec 3, 2016 |
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|
| 1135 |
Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction
Short Name
Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction
|
5 |
Tissue |
Nov 29, 2016 |
Dec 3, 2016 |
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|
| 1136 |
Impaired recruitment , Population trajectory
Short Name
Impaired recruitment , Population trajectory
|
1 |
Population |
Nov 29, 2016 |
Dec 3, 2016 |
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|
| 1137 |
Under carboxylation of osteocalcin, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone
Short Name
Under carboxylation of osteocalcin, Failure to cycle vitamin K epoxide to vitamin K to form
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1138 |
Uncoupling of oxidative phosphorylation, Reduced ability to generate ATP
Short Name
Uncoupling of oxidative phosphorylation, Reduced ability to generate ATP
|
2 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|
| 1139 |
Increased, water retention in foot
Short Name
Increased, water retention in foot
|
0 |
Organ |
Nov 29, 2016 |
Dec 3, 2016 |
97: 5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline
|
| 1140 |
Delayed, Sexual maturity
Short Name
Delayed, Sexual maturity
|
0 |
Individual |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1141 |
Decreased, Reproductive Success
Short Name
Decreased, Reproductive Success
|
0 |
Individual |
Nov 29, 2016 |
Dec 3, 2016 |
4 AOPs
|
| 1142 |
Increased, valve movement
Short Name
Increased, valve movement
|
1 |
Tissue |
Nov 29, 2016 |
Dec 3, 2016 |
4 AOPs
|
| 1143 |
Depletion, energy reserves
Short Name
Depletion, energy reserves
|
0 |
Individual |
Nov 29, 2016 |
Dec 3, 2016 |
97: 5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline
|